BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2830050)

  • 1. Changes in serum enzyme activity after transcatheter arterial embolization for hepatic neoplasm.
    Yoshikawa C; Shimojo N; Naka K; Akai T; Okuda K; Kaminou T; Yamada T; Nakatsuka H
    Clin Biochem; 1987 Dec; 20(6):435-40. PubMed ID: 2830050
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of nontumorous tissue damage by transcatheter arterial embolization for hepatocellular carcinoma.
    Khan KN; Nakata K; Kusumoto Y; Shima M; Ishii N; Koji T; Nagataki S
    Cancer Res; 1991 Oct; 51(20):5667-71. PubMed ID: 1717151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the therapeutic effect of transcatheter arterial embolization for hepatocellular carcinoma.
    Okusaka T; Okada S; Ueno H; Ikeda M; Yoshimori M; Shimada K; Yamamoto J; Kosuge T; Yamasaki S; Iwata R; Furukawa H; Moriyama N; Sakamoto M; Hirohashi S
    Oncology; 2000 May; 58(4):293-9. PubMed ID: 10838494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Evaluation of transcatheter arterial embolization in terms of serum alpha-fetoprotein doubling time in hepatocellular carcinoma].
    Kanno T; Harihara S; Kim K; Kimura S; Tamori A; Kuroki T; Mizoguchi Y; Kobayashi K; Monna T; Nakamura K
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):683-7. PubMed ID: 2451472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Transcatheter arterial embolization therapy for hepatoma--assessment in blood chemistry (author's transl)].
    Yamada R; Nakatsuka H; Nakamura K; Sato M; Itami M; Kobayashi N; Tamaoka K; Oda J; Minakuchi K; Onoyama Y; Kanno T; Marumo T; Monna T; Yamamoto S
    Nihon Shokakibyo Gakkai Zasshi; 1981 Feb; 78(2):214-21. PubMed ID: 6264184
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of fructose 1,6-diphosphate aldolase to detect tumour necrosis after transcatheter arterial embolization of hepatocellular carcinoma.
    Khan KN; Nakata K; Kusumoto Y; Nakao K; Kato Y; Nagataki S
    J Gastroenterol Hepatol; 1998 Feb; 13(2):192-6. PubMed ID: 10221823
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Transcatheter arterial embolization with hepatic arterial induction of endogenous TNF in hepatocellular carcinoma].
    Takekoshi H; Oyama R
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 2):2845-8. PubMed ID: 2476966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum vascular endothelial growth factor in the course of transcatheter arterial embolization of hepatocellular carcinoma.
    Suzuki H; Mori M; Kawaguchi C; Adachi M; Miura S; Ishii H
    Int J Oncol; 1999 Jun; 14(6):1087-90. PubMed ID: 10339662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes of serum 7S fragment of type IV collagen and N-terminal propeptide of type III procollagen after transcatheter arterial embolization as a model of acute liver injury.
    Suou T; Yamada S; Kobayashi J; Hoshino U; Nishimuki E; Kawasaki H
    Hepatology; 1993 Oct; 18(4):809-15. PubMed ID: 7691706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in serum human hepatocyte growth factor levels after transcatheter arterial embolization and partial hepatectomy.
    Kaneko A; Hayashi N; Tanaka Y; Ito T; Kasahara A; Kubo M; Mukuda T; Fusamoto H; Kamada T
    Am J Gastroenterol; 1992 Aug; 87(8):1014-7. PubMed ID: 1322635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum interleukin 6 as a predicator of the therapeutic effect and adverse reactions after transcatheter arterial embolization.
    Yamazaki H; Nishimoto N; Oi H; Matsushita M; Ogata A; Shima Y; Inoue T; Tang JT; Yoshizaki K; Kishimoto T
    Cytokine; 1995 Feb; 7(2):191-5. PubMed ID: 7780039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Changes in ketone body ratio and levels of pyruvate and lactate in arterial blood of patients with hepatocellular carcinoma after transcatheter arterial embolization].
    Mizobuchi N; Kuwao F; Takeda I; Takemura T; Morita S; Horimi T; Takahashi I
    Rinsho Byori; 1990 Jul; 38(7):825-9. PubMed ID: 2169547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT).
    Tsushima Y; Unno Y; Koizumi J; Kusano S
    Dig Dis Sci; 1998 Feb; 43(2):317-22. PubMed ID: 9512124
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical significance of serum and urinary neopterins after transcatheter arterial embolization for hepatocellular carcinoma].
    Godai K; Daito K; Yamada S; Uemasu J; Horie Y; Suou T; Kawasaki H
    Nihon Shokakibyo Gakkai Zasshi; 1994 Jun; 91(6):1097-103. PubMed ID: 8028202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-fetoprotein in patients with hepatocellular carcinoma after transcatheter arterial embolization.
    Hsieh MY; Lu SN; Wang LY; Liu TY; Su WP; Lin ZY; Chuang WL; Chen SC; Chang WY
    J Gastroenterol Hepatol; 1992; 7(6):614-7. PubMed ID: 1283085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of transcatheter hepatic arterial embolization on coagulation and fibrinolysis in patients with hepatocellular carcinoma.
    Sakon M; Kambayashi J; Taniguchi K; Yoshida T; Shiba E; Kawasaki T; Tsuji Y; Yukawa M; Murata K; Gotoh M
    Am J Gastroenterol; 1991 Dec; 86(12):1800-3. PubMed ID: 1660219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of segmental transcatheter arterial chemoembolization on branched chain amino acids and tyrosine ratio in patients with hepatocellular carcinoma.
    Inoue H; Ito T; Siraki K; Sugimoto K; Sakai T; Oomori S; Takase K; Nakano T
    Int J Oncol; 2000 Nov; 17(5):977-80. PubMed ID: 11029501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemodynamic changes after transcatheter arterial embolization of hepatocellular carcinomas.
    Taourel P; Dauzat M; Lafortune M; Pradel J; Rossi M; Bruel JM
    Radiology; 1994 Apr; 191(1):189-92. PubMed ID: 8134569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acute pancreatitis after transcatheter arterial embolization (TAE) for hepatocellular carcinoma.
    Kishimoto W; Nakao A; Takagi H; Hayakawa T
    Am J Gastroenterol; 1989 Nov; 84(11):1396-9. PubMed ID: 2479261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Usefulness of partial splenic embolization (PSE) in hepatocellular carcinomas showing a risk of gastrointestinal bleeding after transcatheter arterial embolization (TAE)].
    Ohmoto K; Yamamoto R; Yamamoto S; Ideguchi S; Saito I; Wada A; Takatori K; Ohumi T; Hino K; Hirano Y
    Gan No Rinsho; 1989 May; 35(6):690-5. PubMed ID: 2542638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.